Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils.
This study is focused on the functional significance of neutrophil lactosylceramide (LacCer)-enriched microdomains, which are involved in the initiation of a signal transduction pathway leading to superoxide generation. Treatment of neutrophils with anti-LacCer antibody, T5A7 or Huly-m13, induced superoxide generation from the cells, which was blocked by PP1, a Src kinase inhibitor; wortmannin, a phosphatidylinositol-3 kinase inhibitor; SB203580, a p38 mitogen-activated protein kinase (MAPK) inhibitor; and H7, an inhibitor for protein kinase C. When promyelocytic leukemia HL-60 cells were differentiated into neutrophilic lineage by dimethyl sulfoxide (DMSO) treatment, they acquired superoxide-generating activity but did not respond to anti-LacCer antibodies. Density gradient centrifugation revealed that LacCer and Lyn were recovered in detergent-insoluble membrane (DIM) of neutrophils and DMSO-treated HL-60 cells. However, immunoprecipitation experiments indicated that LacCer was associated with Lyn in neutrophils but not in DMSO-treated HL-60 cells. Interestingly, T5A7 induced the phosphorylation of Lyn in neutrophils but not in DMSO-treated HL-60 cells. Moreover, T5A7 induced the phosphorylation of p38 MAPK in neutrophils. T5A7-induced Lyn phosphorylation in neutrophil DIM fraction was significantly enhanced by cholesterol depletion or sequestration with methyl-beta-cyclodextrin or nystatin. Collectively, these data suggest that neutrophils are characterized by the presence of cell surface LacCer-enriched glycosphingolipid signaling domain coupled with Lyn and that the ligand binding to LacCer induces the activation of Lyn, which may be suppressibly regulated by cholesterol, leading to superoxide generation through the phosphatidylinositol-3 kinase-, p38 MAPK-, and protein kinase C-dependent signal transduction pathway.
Iwabuchi
Kazuhisa
K
Department of Biochemistry, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. iwabuchi@med.juntendo.ac.jp
Nagaoka
Isao
I
D000906:Antibodies / Q000494:pharmacology; D015703:Antigens, CD; D002454:Cell Differentiation / Q000187:drug effects; D002462:Cell Membrane / Q000737:chemistry; D002499:Centrifugation, Density Gradient; D003505:Cyclodextrins / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006028:Glycosphingolipids / Q000737:chemistry* / Q000378:metabolism*; D018922:HL-60 Cells; D006801:Humans; D007790:Lactosylceramides / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D008055:Lipids / Q000032:analysis; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D009504:Neutrophils / Q000201:enzymology / Q000378:metabolism* / Q000648:ultrastructure; D009761:Nystatin / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction; D013481:Superoxides / Q000378:metabolism*; D047392:beta-Cyclodextrins; D048051:p38 Mitogen-Activated Protein Kinases; D019061:src-Family Kinases / Q000032:analysis / Q000378:metabolism
D000906:Antibodies; D015703:Antigens, CD; D003505:Cyclodextrins; D004121:Dimethyl Sulfoxide; D004791:Enzyme Inhibitors; D006028:Glycosphingolipids; D007790:Lactosylceramides; D008055:Lipids; D020928:Mitogen-Activated Protein Kinases; D009761:Nystatin; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011493:Protein Kinase C; D013481:Superoxides; D047392:beta-Cyclodextrins; D048051:p38 Mitogen-Activated Protein Kinases; D019061:src-Family Kinases; C009744:CDw17 antigen; C060902:lyn protein-tyrosine kinase; C031215:betadex